Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

The role of mitochondria in the oncogenic signal transduction.

Frezza C.

Int J Biochem Cell Biol. 2014 Mar;48:11-7. doi: 10.1016/j.biocel.2013.12.013. Epub 2014 Jan 4. Review.

PMID:
24397955
2.

The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.

Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Saavedra E, Moreno-Sánchez R.

Mol Aspects Med. 2010 Apr;31(2):145-70. doi: 10.1016/j.mam.2010.02.008. Epub 2010 Mar 2. Review.

PMID:
20206201
3.

Mitochondrial chaperones in cancer: from molecular biology to clinical diagnostics.

Czarnecka AM, Campanella C, Zummo G, Cappello F.

Cancer Biol Ther. 2006 Jul;5(7):714-20. Epub 2006 Jul 1. Review.

PMID:
16861898
4.

Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways.

Kaipparettu BA, Ma Y, Park JH, Lee TL, Zhang Y, Yotnda P, Creighton CJ, Chan WY, Wong LJ.

PLoS One. 2013 May 9;8(5):e61747. doi: 10.1371/journal.pone.0061747. Print 2013.

5.

Mitochondria and Cancer.

Zong WX, Rabinowitz JD, White E.

Mol Cell. 2016 Mar 3;61(5):667-676. doi: 10.1016/j.molcel.2016.02.011. Review.

6.

Mitochondrial contributions to cancer cell physiology: redox balance, cell cycle, and drug resistance.

Dorward A, Sweet S, Moorehead R, Singh G.

J Bioenerg Biomembr. 1997 Aug;29(4):385-92. Review.

PMID:
9387099
7.

The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival.

García-Bermúdez J, Cuezva JM.

Biochim Biophys Acta. 2016 Aug;1857(8):1167-1182. doi: 10.1016/j.bbabio.2016.02.004. Epub 2016 Feb 12.

8.

ROS, autophagy, mitochondria and cancer: Ras, the hidden master?

Bellot GL, Liu D, Pervaiz S.

Mitochondrion. 2013 May;13(3):155-62. doi: 10.1016/j.mito.2012.06.007. Epub 2012 Jun 29. Review.

PMID:
22750269
9.

Oncometabolites: Unconventional triggers of oncogenic signalling cascades.

Sciacovelli M, Frezza C.

Free Radic Biol Med. 2016 Nov;100:175-181. doi: 10.1016/j.freeradbiomed.2016.04.025. Epub 2016 Apr 23. Review.

10.

Mitochondrial defect drives non-autonomous tumour progression through Hippo signalling in Drosophila.

Ohsawa S, Sato Y, Enomoto M, Nakamura M, Betsumiya A, Igaki T.

Nature. 2012 Oct 25;490(7421):547-51. doi: 10.1038/nature11452. Epub 2012 Sep 30.

PMID:
23023132
11.

Chronic inflammation and cancer: the role of the mitochondria.

Kamp DW, Shacter E, Weitzman SA.

Oncology (Williston Park). 2011 Apr 30;25(5):400-10, 413. Review.

12.

The role of microRNAs in mitochondria in cancer.

Bienertova-Vasku J, Sana J, Slaby O.

Cancer Lett. 2013 Aug 9;336(1):1-7. doi: 10.1016/j.canlet.2013.05.001. Epub 2013 May 9. Review.

PMID:
23665507
14.

Mitochondria and cell signalling.

Tait SW, Green DR.

J Cell Sci. 2012 Feb 15;125(Pt 4):807-15. doi: 10.1242/jcs.099234. Review.

15.

The voltage-dependent anion channel (VDAC): function in intracellular signalling, cell life and cell death.

Shoshan-Barmatz V, Israelson A, Brdiczka D, Sheu SS.

Curr Pharm Des. 2006;12(18):2249-70. Review.

PMID:
16787253
16.

The Role of Mitochondria in Cancer Induction, Progression and Changes in Metabolism.

Rogalinska M.

Mini Rev Med Chem. 2016;16(7):524-30. Review.

PMID:
26471969
17.

Cancer metabolism: current perspectives and future directions.

Muñoz-Pinedo C, El Mjiyad N, Ricci JE.

Cell Death Dis. 2012 Jan 12;3:e248. doi: 10.1038/cddis.2011.123. Review.

18.

Mitochondrial biogenesis: pharmacological approaches.

Valero T.

Curr Pharm Des. 2014;20(35):5507-9.

PMID:
24606795
19.

Targeting mitochondria for cancer treatment - two types of mitochondrial dysfunction.

Pokorný J, Pokorný J, Kobilková J, Jandová A, Vrba J, Vrba J.

Prague Med Rep. 2014;115(3-4):104-19. doi: 10.14712/23362936.2014.41. Review.

20.

Mitochondria as signaling organelles.

Chandel NS.

BMC Biol. 2014 May 27;12:34. doi: 10.1186/1741-7007-12-34. Review.

Supplemental Content

Support Center